fentanyl citrate

Poland

Drugs containing this active substance

  • AUROFENA

    The medicine is used in adult patients with cancer to relieve so-called breakthrough pain. This is sudden, additional pain that occurs despite regular intake of other opioid medicines used to treat constant pain.

    Form: tablets, buccal

    Active substance Dosage
    fentanyl citrate 157 mcg

    ATC: N02AB03

    Manufacturer: Ardena Pamplona S.L. Bluepharma Pharmaceutical Industry, S.A.

  • AUROFENA

    This is an analgesic used in adult cancer patients to relieve so-called breakthrough pain. This is sudden, additional pain that occurs despite regular intake of other opioid medications used to control constant pain.

    Form: tablets, buccal

    Active substance Dosage
    fentanyl citrate 314 mcg

    ATC: N02AB03

    Manufacturer: Ardena Pamplona S.L. Bluepharma Pharmaceutical Industry, S.A.

  • AUROFENA

    The medicine is used in adult patients with cancer to relieve so-called breakthrough pain. This is sudden, additional pain that occurs despite regular intake of other opioid medicines used to treat constant pain.

    Form: tablets, buccal

    Active substance Dosage
    fentanyl citrate 628 mcg

    ATC: N02AB03

    Manufacturer: Ardena Pamplona S.L. Bluepharma Pharmaceutical Industry, S.A.

  • FENTANYL WZF

    It is a very potent analgesic used, among other things, to relieve pain during short surgical procedures, to induce anesthesia, to treat severe pain (e.g., post-traumatic or associated with myocardial infarction), and as a respiratory depressant in patients requiring assisted ventilation.

    Form: solution for injection

    Active substance Dosage
    fentanyl citrate 78.55 mcg/ml

    ATC: N02AB03

    Manufacturer: Polpharma Pharmaceutical Works S.A.

  • SUBMENA

    The medicine is intended for adults who must regularly take strong painkillers (opioids) to relieve chronic cancer pain, while also needing additional help in the event of sudden, so-called breakthrough pain.

    Form: tablets, sublingual

    Active substance Dosage
    fentanyl citrate 157 mcg

    ATC: N02AB03

    Manufacturer: G.L. Pharma GmbH

  • SUBMENA

    The medicine is intended for adults who must regularly take strong painkillers (opioids) to relieve chronic cancer pain, and who also require additional help in the event of sudden, so-called breakthrough pain.

    Form: tablets, sublingual

    Active substance Dosage
    fentanyl citrate 0.314 mg

    ATC: N02AB03

    Manufacturer: G.L. Pharma GmbH Kern Pharma S.L. PRASFARMA, S.L.

  • SUBMENA

    The medicine is intended for adults who must regularly take strong painkillers (opioids) to relieve chronic cancer pain, and who also need additional help in the event of sudden, so-called breakthrough pain.

    Form: tablets, sublingual

    Active substance Dosage
    fentanyl citrate 0.628 mg

    ATC: N02AB03

    Manufacturer: G.L. Pharma GmbH Kern Pharma S.L. PRASFARMA, S.L.

  • SUBMENA

    The medicine is intended for adults who must regularly take strong painkillers (opioids) to relieve chronic cancer pain, but do not require treatment for breakthrough pain.

    Form: tablets, sublingual

    Active substance Dosage
    fentanyl citrate 1.257 mg

    ATC: N02AB03

    Manufacturer: G.L. Pharma GmbH Kern Pharma S.L. PRASFARMA, S.L.

  • VELLOFENT

    The medicine is intended for the treatment of breakthrough pain in adult cancer patients who are already using other analgesics to manage chronic cancer pain. Breakthrough pain is sudden, additional pain that occurs despite regular intake of opioid medications.

    Form: tablets, sublingual

    Active substance Dosage
    fentanyl citrate 0.11 mg

    ATC: N02AB03

    Manufacturer: Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Etypharm

  • VELLOFENT

    The medicine is intended for the treatment of breakthrough pain in adult cancer patients who are already using other analgesics to manage chronic pain. Breakthrough pain is a sudden, additional pain that occurs despite regular intake of opioid medications.

    Form: tablets, sublingual

    Active substance Dosage
    fentanyl citrate 0.42 mg

    ATC: N02AB03

    Manufacturer: Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Ethypharm

  • VELLOFENT

    The medicine is used in adult patients with cancer to treat breakthrough pain. This is sudden, additional pain that occurs despite regular intake of other analgesics used for chronic pain.

    Form: tablets, sublingual

    Active substance Dosage
    fentanyl citrate 0.21 mg

    ATC: N02AB03

    Manufacturer: Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Etypharm

  • VELLOFENT

    The medicine is used in adult patients with cancer to treat breakthrough pain. This is sudden, additional pain that occurs despite regular intake of other analgesics used for chronic pain.

    Form: tablets, sublingual

    Active substance Dosage
    fentanyl citrate 0.63 mg

    ATC: N02AB03

    Manufacturer: Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Ethypharm

  • VELLOFENT

    The medicine is intended for the treatment of breakthrough pain in adult cancer patients who are already using other analgesics to manage chronic pain.

    Form: tablets, sublingual

    Active substance Dosage
    fentanyl citrate 0.84 mg

    ATC: N02AB03

    Manufacturer: Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Etypharm

  • VELLOFENT

    The medicine is intended for adult patients with cancer for the treatment of breakthrough pain. This is sudden, additional pain that occurs despite regular intake of other analgesics used for chronic pain.

    Form: tablets, sublingual

    Active substance Dosage
    fentanyl citrate 1.26 mg

    ATC: N02AB03

    Manufacturer: Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Ethypharm